OCARNO, SWITZERLAND & EASTON, PA – November 7, 2007 – A recently completed U.S. clinical study of HMRlignan™ and hot flashes has shown significant alleviation for women by cutting incidence of hot flashes by 53 percent in postmenopausal women.
The pilot study, entitled, “The effect of HMRlignan™ on mammalian lignan and estrogen metabolite levels in post-menopausal women: A randomized, double-blind, single dummy, parallel group, pilot study,” led by Jay Udani, M.D. and Mary Hardy, M.D. from Medicus Research in Northridge, CA, analyzed changes in enterolactone levels and estrogen metabolites following ingestion of the plant lignan hydroxymatairesinol (HMR) and found significant improvement in reported hot flashes by the study participants.
